Summary of Significant Accounting Policies (Details) - Schedule of finite-lived and indefinite-lived intangible assets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]
Cost	$ 15,518,000
Accumulated Amortization and Impairment	(8,032,636)	$ (7,437,206)
Effect of Foreign Exchange Rates	(642,958)	(639,820)
Net Balance	6,842,406	7,440,974
Trademarks and tradenames [Member] | Curetis N.V [Member]
Summary of Significant Accounting Policies [Line Items]
Cost	1,768,000
Accumulated Amortization and Impairment	(592,893)	(469,011)
Effect of Foreign Exchange Rates	(74,033)	(62,520)
Net Balance	1,101,074	1,236,469
Distributor relationships [Member] | Curetis N.V [Member]
Summary of Significant Accounting Policies [Line Items]
Cost	2,362,000
Accumulated Amortization and Impairment	(528,064)	(417,728)
Effect of Foreign Exchange Rates	(98,907)	(83,525)
Net Balance	1,735,029	1,860,747
A50 – Developed technology [Member] | Curetis N.V [Member]
Summary of Significant Accounting Policies [Line Items]
Cost	349,000
Accumulated Amortization and Impairment	(167,211)	(132,273)
Effect of Foreign Exchange Rates	(14,614)	(12,342)
Net Balance	167,175	204,385
Ares – Developed technology [Member] | Ares Genetics [Member]
Summary of Significant Accounting Policies [Line Items]
Cost	5,333,000
Accumulated Amortization and Impairment	(1,277,401)	(1,010,495)
Effect of Foreign Exchange Rates	(216,471)	(183,132)
Net Balance	3,839,128	4,139,373
A30 – In-Process Research & Development [Member] | Curetis N.V [Member]
Summary of Significant Accounting Policies [Line Items]
Cost	5,706,000
Accumulated Amortization and Impairment	(5,467,067)	(5,407,699)
Effect of Foreign Exchange Rates	(238,933)	(298,301)
Net Balance